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ABSTRACT
Understanding the nature of the free state of ribo-
switch aptamers is important for illuminating com-
mon themes in gene regulation by riboswitches.
Prior evidence indicated the flavin mononucleotide
(FMN)-binding riboswitch aptamer adopted a
‘bound-like’ structure in absence of FMN, suggest-
ing only local conformational changes upon ligand
binding. In the scope of pinpointing the general
nature of such changes at the nucleotide level, we
performed SHAPE mapping experiments using the
aptamer domain of two phylogenetic variants, both
in absence and in presence of FMN. We also solved
the crystal structures of one of these domains both
free (3.3A ˚ resolution) and bound to FMN (2.95A ˚
resolution). Our comparative study reveals that
structural rearrangements occurring upon binding
are restricted to a few of the joining regions that
form the binding pocket in both RNAs. This type of
binding event with minimal structural perturbations
is reminiscent of binding events by conformational
selection encountered in other riboswitches and
various RNAs.
INTRODUCTION
Since the discovery that certain mRNAs can directly bind
metabolites to regulate their own expression [reviewed in
(1,2)], questions pertaining to the mechanistic details of
these ‘riboswitches’ have abounded. In particular, upon
metabolite binding to the ligand-binding (aptamer)
domain, the downstream ‘expression platform’ is parti-
tioned to one of two mutually exclusive secondary struc-
tures by the ‘switching sequence’, a stretch of nucleotides
shared between these two domains (3,4). However, such a
switch, particularly within transcriptional regulators, may
not be reversible, so that once RNA polymerase has
escaped the rho-independent transcriptional terminator;
the riboswitch can no longer abort transcription (5,6).
Thus, these RNA sensors only have a short temporal win-
dow in which to exert their regulatory effect. The aptamer
must be able to fold efﬁciently, rapidly bind a metabolite
and transmit its status to the actively transcribing down-
stream expression platform. The nature of the communi-
cation between these two domains has been only partly
addressed.
To help understand how ligand binding determines
which of the two mutually exclusive riboswitch structures
will be adopted, the 3D structures of over 10 aptamer
domains bound to corresponding metabolites have been
solved [e.g. (7–9) and all reviewed in (10,11)]. In each of
these, the ligand is adjacent to, or directly interacts with
nucleotides of the switching sequence (3,7). The resulting
stabilization of this particular conformation of the
aptamer domain makes the switching sequence unavail-
able to participate in formation of an alternative second-
ary structure (2,3).
Similar levels of detail about the free states of these
RNAs have been scarce. But in each of the four crystal
structures of free aptamers solved to date (12–16), the
RNA architecture closely resembles that of the ligand
bound state. Furthermore, evidence from biochemical
techniques suggests that these ‘bound-like’ structures tra-
pped by the crystal lattice might represent the active con-
formation capable of productively binding ligand (13).
Recently, small angle X-ray scattering (SAXS) data
provided further support to such ligand-binding mechan-
ism, by showing that the ﬂavin mononucleotide (FMN)
riboswitch aptamer from Bacillus subtilis (Figure 1) is
globally folded at physiological magnesium concentra-
tion and undergoes little, if any, conformational change
upon FMN binding (17). In-line and nuclease probing
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Fusobacterium nucleatum (Figure 1), implicated a
number of nucleotides that could be involved in ligand-
dependent conformational changes (18,19). Overall, the
picture of genetic regulation emerging from these studies
is that of RNAs that have the ability to act as regulatory
switches without needing to undergo large ligand-induced
conformational changes (13,20,21).
Here, we present a nucleotide-level analysis of FMN
riboswitch aptamers from B. subtilis and F. nucleatum
(Figure 1). We monitored the structure and folding of
the B. subtilis and F. nucleatum aptamers in solution using
the selective 20-hydroxyl acylation analyzed by primer ex-
tension (SHAPE) chemical footprinting technique (22).
Additionally, we solved the structures of both the free
and bound forms of a sequence variant of the F. nucleatum
aptamer that had been used in prior crystallographic
studies (see ‘Materials and Methods’ section) (19). Our
results yield speciﬁc insights into local conformational
changes in the FMN aptamer domain associated with
folding and ligand binding. These changes are mostly
similar for the two RNAs tested, which makes for an im-
portant consideration to drug designers (23,24), consider-
ing the broad distribution of FMN riboswitches in the
bacterial kingdom (25,26). We also demonstrate that the
aptamer domain of the FMN riboswitch folds coopera-
tively in presence of magnesium, irrespective of the pres-
ence of a ligand. Finally, we show that the only regions
undergoing conformational changes upon ligand binding
are a subset of joining regions that immediately contact
FMN in the crystal structure, including nucleotides from
the switching sequence within J1/2. Our comparison
between the free and bound forms suggests that J1/2
and J6/1 serve as the gate to a binding pocket that is
maintained in an ‘open’ state by J3/4 and J4/5. From
this work, and from the other structures of an aptamer
domain in absence of ligand (12–16) as well as from
various ﬁndings on the behavior of aptamer domains in
solution (12,13,27–29), a model emerges for ligand binding
to riboswitches by conformational selection.
MATERIALS AND METHODS
RNA preparation for chemical probing experiments
The B. subtilis RNA variant was designed to contain resi-
dues 23–166 of the 165 ribD RFN element from Bacillus
subtilis used in previous in vitro studies (Rfam accession
#X59538.1, position range 81–225) (17,18). The F. nucleatum
RNA variant was designed to contain residues 1–112 from a
natural variant of the RFN element from F. nucleatum subsp.
nucleatum ATCC 25586 (Rfam accession #AE009951.2) that
was recently analyzed by crystallography (19). The sequence
is found at positions 10346–10461 and contains ﬁve purine-
to-purine and pyrimidine-to-pyrimidine substitutions from
the sequence found at positions 2491–2606 (Figure 1).
T h e s eR N A sr e p r e s e n tt h ee a r l i e st stage in the transcription-
al timeline in which the aptamer has been transcribed and
magnesium-dependent tertiary structure has been acquired
(3,30). Immediately following this sequence in the B. subtilis
FMN riboswitch, a programmed transcriptional pause gives
the aptamer a multisecond period to interrogate the cellular
environment in the absence of the inﬂuence of downstream
sequences that compete to form alternative structures (6).
Both riboswitch aptamers were inserted into a structure
cassette for SHAPE mapping (31). DNA template synthesis,
transcription reactions and RNA puriﬁcation were
Figure 1. Secondary structure diagrams of the FMN riboswitches from F. nucleatum (left) and B. subtilis (right) used in this study. Black letters,
nucleotides conserved between the two species; blue letters, nucleotides found only in F. nucleatum; orange letters, nucleotides found only in
B. subtilis; green letters, FMN; bold letters, nucleotides interacting with FMN, either directly or via a magnesium ion (19); lower case letters in
parentheses, nucleotide changes in the variant used by (19); black ﬁgures, species-speciﬁc numbering; blue ﬁgures, F. nucleatum numbering overlayed
on the B. subtilis sequence. Inset at the bottom right of each diagram, nucleotide ranges of each joining region. Interactions labeled using the
Leontis–Westhof nomenclature (67).
Nucleic Acids Research, 2011,Vol.39, No. 19 8587performed as previously described (32), with minor modiﬁ-
cations (Methods in Supplementary Data).
SHAPE Mg titrations
Four independent mapping experiments were performed
according to published SHAPE protocols (31). The RNA
was diluted to a concentration of 2.0mMi n5 0 m M
HEPES pH 8.0, incubated for 2min at 95 C followed by
3min at 4 C. Two parts of this RNA solution were
combined to one part of a folding buffer so that the fol-
lowing buffer and ionic concentrations would be reached:
100mM KCl, 0–15mM MgCl2 ([MgCl2] chosen: 0, 0.025,
0.1, 0.25, 0.5, 1.0, 2.0, 5.0, 15.0mM (replicates 1–3); 20
and 50mM MgCl2 were added for replicate 4), 50mM
HEPES pH 8.0, ±10.0mM FMN (Sigma-Aldrich). This
mixture was incubated for 10min at 37 C.
NMIA or 1M7 modiﬁcation (33) was performed in the
presence of 6.5mM NMIA or 1M7 (gift from S. Mortimer
and K. Weeks) for 45min (NMIA), 30min (1M7, no
FMN; B. subtilis RNA), or for 12min (1M7, with
FMN; B. subtilis RNA) at 37 C, at each magnesium con-
centration speciﬁed above. Samples were precipitated for
16h at  20 C in 70% EtOH, 100mM Na acetate pH 5.3,
in the presence of 20mg of glycogen, centrifuged for 35min
at 13500g, dried for 10min under vacuum and resus-
pended in 9.0ml 0.5  T.E. buffer (10mM Tris, 1mM
EDTA, pH 8.0).
Primer extension by reverse transcription was per-
formed as described (31), except that the extension step
was performed for 15min at 50 C. Primers used for the
extension were designed to pair either with a binding site
in the 30 structure cassette (for B. subtilis and F. nucleatum)
or with an internal site (for B. subtilis), in order to monitor
the 50-end of the RNA. The internal primer was comple-
mentary to nucleotides 105–142 (30-read), or 82–112
(50-read). Extensions products were resolved by analytical
gel electrophoresis, as described (32) (Methods in
Supplementary Data).
The gel image (.gel ﬁle; Supplementary Figure S1) was
opened and processed in SAFA v. 1.1 (34,35). For nor-
malization purposes, a set of 4nt was determined that com-
prised the nucleotides most commonly selected by SAFA
throughout the four independent experiments (Methods in
Supplementary Data, Supplementary Figures S1 and S2).
The option of applying factors to correct for linear correl-
ation between NMIA reactivity and magnesium concen-
tration observed for a model nucleotide was initially
considered, as suggested in (33). However, we did not
carry out this correction after observing no signiﬁcant
change in NMIA reactivity as a function of magnesium
concentration with the B. subtilis RNA (Supplementary
Figure S2).
The resulting normalized .txt ﬁle was further analyzed
by calculating the extent of adduct formation (E) and the
fraction folded (F) for each residue at each magnesium
concentration tested (36). The extent of adduct formation
of residue i for MgCl2 concentration x is described by:
Eix ¼
Iix  ð
P
IiLÞ
P
Iix  IiL
ð1Þ
where Iix is the number of counts for residue i, Iix is the
sum of the counts for all assessed positions when
[MgCl2]=x, and IiL is the lowest number of counts for
residue i observed at any [MgCl2] (typically <1.0mM).
The fraction folded is expressed as Fix=Eix/EiH, where
EiH is the highest extent of adduct formation at position i
calculated at any [MgCl2] (typically >1.0mM). Fix
provides an estimate of the relative extent of folding at
each residue, assuming a two-state model.
The fraction folded was plotted against the magnesium
concentration on a semi-log graph (36). The sigmoidal
curve—observed for cooperative transitions—was ﬁtted
using a Hill equation in Kaleidagraph v. 4.0 (Synergy
Software). Obvious outliers were ignored for the ﬁtting
procedure, according to the following criteria: similarity
of the ﬁts between independent experiments and similarity
of the ﬁts between adjacent residues, unless a change or
discrepancy was revealed on the gel. Mid-point values for
KD (e.g. [Mg]1/2) and nH (cooperativity index) were extra-
polated from the ﬁt when the correlation coefﬁcient
R
2 was >0.91 (Supplementary Figure S3). These values
were averaged and the standard error of the mean was
calculated from a statistical propagation of error analysis.
SHAPE temperature surveys
Three independent mapping experiments were performed
as described above, but only at 5.0mM MgCl2.
Temperatures were sampled in 5 C intervals over a
20–90 C range. NMIA modiﬁcation at each temperature
proceeded for ﬁve half-lives as described (37). Samples
were precipitated and extended by reverse transcription
as described above, except that the internal primer for
the B. subtilis riboswitch was not employed. Products
were similarly analyzed by gel electrophoresis.
The gel image (.gel ﬁle; Supplementary Figure S4) was
opened in SAFA v. 1.1 (34,35) and processed as described
above. Because of hyper-modiﬁcation of the RNA at tem-
peratures >65 C (Supplementary Figure S4), invariant
residues were chosen for normalization that matched some
or all of the following criteria: (i) they corresponded to RT
stops (identiﬁed for example from temperature survey ex-
periments performed in absence of NMIA; Supplementary
Figure S5); (ii) their intensity decreased as temperature
increased, and possibly increased again when T>75 C
(e.g. see nucleotides 123 and 142, Supplementary
Figure S5); (iii) they spanned the gel (less critical for the
long runs; Supplementary Figures S4 and S5); (iv) they
gave consistent results when applied to independent ex-
periments (Supplementary Figure S6). We settled on the
set of invariants that would lead to normalized re-
activities on average better ﬁtted to a curve describing a
unimolecular melting transition (Supplementary Figures
S4–S7 and Methods in Supplementary Data) (37).
Fitting ignored data points that were obvious outliers
(similar criteria as for the ﬁts of the Mg titrations) or
that showed a signiﬁcant decrease in reactivity at higher
temperatures (32).
Mid-point values for Tm (melting temperature) were
extrapolated from the ﬁt when the correlation coefﬁcient
R
2 was >0.91 (Supplementary Figure S6). These values
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Crystallization
In our crystallization trials, we employed the two-piece F.
nucleatum FMN riboswitch used in the study by Serganov
et al. (19). Strand ‘B’ was engineered to include an optimal
transcription start site [alteration of 50-GCU-30 in (19) to
50-GGA-30; strand ‘A’ was correspondingly engineered to
maintain Watson–Crick pairing in P4; Supplementary
Figure S8]. The 2-nt overhang at the 30 e n do fs t r a n d‘ A ’
(19) was kept, but changed from 50-UU-30 into 50-AU-30.
This ‘wild-type’ sequence of the FMN riboswitch
(Supplementary Figure S8) was used as the starting
point of a mutational survey, according to a strategy
similar to that employed for the SAM-I riboswitch (38)
(Supplementary Table S5). Following synthesis of each
strand by transcription using T7 RNA polymerase, the
strands were puriﬁed using standard techniques (32,39),
and annealed using the published protocol (19). The set
of RNAs that yielded the highest quality diffraction in
both the free and FMN-bound forms were: (strand ‘A’)
50-GGAUCUUCGGGGCAGGGUGAAAUUCCCGAC
CGGUGGUAUAGUCCACGAAUCCAU and (strand
‘B’) 50-GGAUUGAUUUGGUGAAAUUCCAAAACC
GACAGUAGAGUCUGG-AUGAGAGAAGAUUCG
(same sequence as our ‘wild-type’ but with a 30-G
overhang on strand ‘B’; Supplementary Figure S8 and
Supplementary Table S5). After annealing, the two-piece
RNA was crystallized using the hanging drop method in
which 1ml of 100mM RNA was mixed with 1ml of mother
liquor and incubated at 20 C. The mother liquor con-
tained the following components: 11% PEG-4000,
0.32M MgCl2 and 0.01M Tris–Cl, pH 8.4 (free RNA);
15% PEG-monomethyl 550 ether, 0.1M MgCl2, and
0.05M Na–HEPES, pH 7.0 and 1mM FMN
(FMN-bound RNA). The crystals took 2–3days to
reach full size ( 150mm in each dimension). Prior to
cryoprotection, the crystals were dehydrated in a ﬁrst
step over mother liquor plus 10% mother liquor and
incubated at 20 C for 12–16h. The crystals were cry-
oprotected by soaking for  5min in mother liquor plus
25% glycerol and ﬂash frozen in liquid nitrogen.
Data collection and reﬁnement
Data for crystals of the free and bound states were col-
lected on beamline X29A (free) and X25A (FMN bound)
at the Brookhaven National Synchrotron Light Source.
The resulting data sets were integrated and scaled using
the HKL2000 package (40). As an initial search model for
molecular replacement, the previously determined struc-
ture of the FMN riboswitch aptamer domain (PDB ID
3F2Q) (19) was used, after removal of solvent, metal ions,
and FMN. Following calculation of an initial electron
density map, the model was manually adjusted in COOT
v. 0.6 (41), along with addition of ligand, where appropri-
ate. The model was further reﬁned using simulated anneal-
ing in CNS v. 1.1 (42) and semi-automated building of
solvent and hydrated metal ions. The ﬁnal stages of reﬁne-
ment were performed using PHENIX v. 1.7-650 (43).
Reﬁnement comprised four macro cycles of energy mini-
mization of individual coordinates, and reﬁnement of
group atomic displacement parameters including transla-
tion/libration/screw (TLS) vibrational motions for 12
segments, of occupancy, and of ordered solvent (water)
(44). Models were validated using MOLPROBITY (45)
and adjusted for lowest all-atom clash scores by further
reﬁnement using a reference A-form helix built in COOT
(50-CCACUUCCACAUC-30 and complementary strand),
with automatic optimization of the X-ray target weight.
Final R/Rfree (%) were 20.6/25.7 (free) and 20.4/23.1
(bound) (Table 2). 3D structures were superimposed
using THESEUS (46). Figures were prepared using the
MacPyMOL Molecular Graphics System, v. 0.99
(Schro ¨ dinger, LLC). Models and structure factors were
deposited in the RCSB Protein Data Bank under the
PDB IDs 2YIF (free) and 2YIE (FMN bound).
RESULTS
The aptamer domain of the FMN riboswitch is globally
pre-organized in absence of ligand
To explore how the local and global architectures of the
FMN aptamer were affected by FMN, we carried out
SHAPE structure mapping, which involves the reaction be-
tween N-methylisatoic anhydride (NMIA) and the
20-hydroxyl group of nucleotides not embedded in
Watson–Crick pairs (22). In the case of riboswitches, the
differences between reactivities to NMIA in absence and
in presence of the cognate ligand reﬂect differences in the
degrees of tertiary architecture adopted by the two popu-
lations of structures being analyzed (13,32). Furthermore,
we observed reactivity changes both over a range of
magnesium concentrations (0–15mM) at a constant tem-
perature (37 C), as well as over a range of temperatures
(20–90 C) at a constant magnesium concentration
(5.0mM). These complementary strategies allow for a
nucleotide-level monitoring of folding cooperativity and
of changes in conformational sampling associated with
diverse degrees of tertiary structure formation within the
RNA population (13,32,37).
Visual inspection of the magnesium titration data re-
vealed that in both the B. subtilis and F. nucleatum
RNAs, most of the nucleotides known to participate in
secondary structure elements (Figure 1) were unmodiﬁed
by NMIA in absence of magnesium, regardless of the
presence of FMN (Figure 2a and b). Upon increase of
the magnesium concentration to 0.25–1mM, the remain-
ing nucleotides in helical regions (parts of paired regions
P4 and P5 for F. nucleatum) underwent transitions from
higher to lower NMIA modiﬁcation levels. The exception
was loops L3a and L4, which underwent a converse tran-
sition (Figure 2a and b). This behavior highlighted the
formation of the structural features seen in the crystal
structure of the F. nucleatum RNA (19), such as the for-
mation of tertiary interactions between peripheral
domains like T-loop/T-loop receptor interactions (L2–L6
and L3–L5) and loop–helix interactions (L6–P2 and
L3–P5). It also denoted a particular structural transition
leading to the stabilization of P3a and P4 and the
Nucleic Acids Research, 2011,Vol.39, No. 19 8589progressive exposure to the solvent of L3a and L4.
Together, these ﬁndings supported that both aptamer
domains were globally folded at physiological magnesium
concentrations (0.5–1.5mM). This observation is in agree-
ment with previous studies performed on these two
aptamer domains by either in-line probing (18,24), enzym-
atic footprinting (19) or small angle X-ray scattering
(SAXS) (17).
FMN marginally increases RNA folding cooperativity
and stability
The degree of cooperativity of the folding transitions ob-
served in the magnesium titrations was quantiﬁed as
described previously for Fe(II)–EDTA chemical probing
data acquired for the Tetrahymena group I intron (36).
Using a mathematical model that assumes two-state
folding transitions, we calculated the fraction of molecules
in the ﬁnal folded state, at each position of the RNA and
at each magnesium concentration tested (see ‘Materials
and Methods’ section). The resulting sigmoidal curves
with sharp transitions indicated a high cooperativity of
folding for  65% of the residues that displayed reactivity
change to NMIA as a function of magnesium concentra-
tion (not all residues displayed a cooperative folding be-
havior both in absence and in presence of ligand;
Supplementary Figures S1–S3, Supplementary Tables S1
and S2). The average of the corresponding midpoint
([Mg
2+]1/2) values was within 0.7–1.0mM for both
RNAs in the absence of FMN, and slightly lower in
presence of ligand (Table 1). Furthermore, the highest
[Mg
2+]1/2 value was lower in presence of FMN for the
B. subtilis RNA (Table 1). Finally, out of all the
Figure 2. Magnesium-dependent chemical probing of the F. nucleatum and B. subtilis RNAs. (a) Long run (top) and short run (bottom), obtained
with the F. nucleatum riboswitch. (b) Short run after extension using an internal primer (top) and short run after extension using the regular primer
(bottom), obtained with the B. subtilis riboswitch. [MgCl2] were 0, 0.025, 0.1, 0.25, 0.5, 1.0, 2.0, 5.0 and 15.0mM. Controls: Lane 0, no Mg, no
ligand, no NMIA; lane 0F, no Mg, 10mM FMN, no NMIA. Arrowheads: residues of interest (see main text). The gels were aligned in SAFA
(34,35). Full-length gels and additional control experiments shown in Supplementary Figures S1 and S2. (c) The nucleotides that undergo
FMN-induced conformational changes in F. nucleatum and B. subtilis are shown in red on the crystal structure of the FMN-bound riboswitch
(19). (d) Fold change in [Mg]1/2 upon ligand binding (+ligand/no ligand) for both riboswitches. Colored solid line (blue, F. nucleatum; orange,
B. subtilis), median value. Shaded box (same color coding), standard error around the median. In panel (d), the numbering of the B. subtilis RNA
was aligned to that of the F. nucleatum RNA, as shown in Figure 1.
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nucleatum) and 22% (B. subtilis) had a [Mg
2+]1/2 value
superior to 1.5mM in absence of ligand, compared to
only 8% in presence of FMN (Supplementary Tables S1
and S2). These results supported a slight, but reprodu-
cible, stabilization of the aptamer domain upon FMN
binding through a small increase in folding cooperativity.
The SHAPE temperature surveys further support a
similar but somewhat enhanced folding of the FMN
riboswitch aptamer domain in presence of FMN.
Examination of the gels revealed that both aptamers
unfolded similarly as temperature increased, as visualized
by the progressive augmentation in the number of bands,
particularly around 65 C (Figure 3a and b). The average
observed melting point (Tm) calculated from the two-state
folding transition of each measurable nucleotide (see
‘Materials and Methods’ section) slightly increased upon
ligand binding [average Tm±standard deviation (SD)]:
64.9±4.6 C (unbound) and 69.3±4.3 C (FMN bound)
for B. subtilis; 60.5±8.2 C (unbound) and 67.7±5.6 C
(FMN bound) for F. nucleatum (Supplementary Tables S3
and S4). Overall, the low levels of stabilization of the
global structure and of folding enhancement we
observed upon FMN binding are consistent with a
mostly preformed architecture in absence of ligand.
Furthermore, productive interaction of the FMN with
the core of the junction provides only a modest additional
stabilization of the RNA.
The major conformational changes associated with FMN
binding are restricted to the joining regions that deﬁne the
ligand-binding site
In spite of this general pre-organized state of the aptamer
domain, striking changes in banding patterns were noted
upon addition of FMN within joining regions J1/2
(residues 10 in F. nucleatum, and 34 in B. subtilis), J3/4
(residues 48 in F. nucleatum, and 91–92 in B. subtilis), J4/5
(residues 61–62 in F. nucleatum, and 113–114 in B. subtilis)
and J6/1 (residues 98–103 in F. nucleatum, and 151–156 in
B. subtilis) (Figure 2a and b). In absence of ligand, these
residues displayed an increasing reactivity to NMIA upon
magnesium concentration increase. In presence of FMN,
all of these residues except one (U100 in F. nucleatum, and
its equivalent U153 in B. subtilis) showed a decreased re-
activity at all magnesium concentrations tested. This result
is consistent with the structural organization of the
FMN-binding site around FMN as seen in the crystal
structure of the F. nucleatum FMN-bound
aptamer domain (19). Nucleotides in J1/2, J3/4, J4/5 and
A98 and A99 in J6/1 are located within 4 A ˚ of FMN
(Figure 2c) and most interact directly with FMN via
hydrogen bonds and p-stacking. As suggested by its
strong modiﬁcation by NMIA in presence of FMN,
U100 is bulged out, facing the solvent, in a ﬂexible and
highly reactive conformation (37,47) (Figure 2a–c). The
remaining residues in J6/1 that displayed decreased re-
activity to NMIA (98, 101–103) are not part of the ﬁrst
layer of residues that directly contact FMN, but are con-
strained through interactions with residues that contact
FMN. In summary, the drop in reactivity to NMIA
upon addition of the ligand observed for these joining
region nucleotides inferred that ligand-induced stabiliza-
tion happens principally at the binding site but extends to
J6/1 nucleotides located up to 10A ˚ away.
In order to assess whether the different conformations
of these joining regions in the free and FMN-bound popu-
lations were accompanied by changes in their dependence
on the magnesium concentration for folding, we plotted
the fold change in [Mg
2+]1/2 values for each residue
(Figure 2d). While >90% of the residues showed no sig-
niﬁcant fold change, fold change in [Mg
2+]1/2 values were
observed principally for nucleotides within J3/4, J4/5 and
J6/1, as well as nucleotides adjacent to the joining regions
(33 adjacent to J2/3, 49 and 50 adjacent to J3/4, 64
adjacent to J4/5, 85 adjacent to J5/6, and 98 adjacent to
J6/1; aligned numbering for B. subtilis and F. nucleatum,
Figure 1). These changes were predominantly comprised
between 4 and 9 and observed in the B. subtilis aptamer
domain mostly (Figure 2d), which indicated that for this
RNA, a larger magnesium concentration was required to
achieve the local reorganization of the binding pocket con-
ducive to FMN binding. This somewhat unexpected ob-
servation could be linked to elongated P3 and P4 whose
presence could affect the reorganization at J3/4 and J4/5
observed between the free and bound structures (see
below).
Finally, we calculated the Tm differences between the
free and the FMN-bound populations (Tm,=
Tm,bound–Tm,free) to speciﬁcally highlight the effect of
FMN on folding of the joining regions (Supplementary
Tables S3 and S4). Although the average Tm was typic-
ally comprised within 0–5 C for most of the RNA (see
above), the highest Tm values were  20–40 C for J1/2
and J6/1 of F. nucleatum, and about  10–30 C for B.
subtilis (Figure 3c and d). Moderate Tm values were
also observed at J3/4 and J4/5 ( 4–8 C for F. nucleatum;
 9–16 C for B. subtilis). Together with the results of the
magnesium survey, these ﬁndings indicated a ligand-
induced conformational stabilization of the joining regions
around the binding pocket. When these ﬁndings were
combined to the observation of higher observed Tm
values (by  10 C) for residues belonging to P1 in the
bound form (Figure 3c and d; Supplementary Tables S3
and S4), they also offered evidence for stabilization of the
switching sequence upon ligand binding (residues 6–11 in
F. nucleatum numbering). Such effect could promote for-
mation of the transcription terminator in presence of
FMN (18).
Table 1. Transition midpoints for magnesium titrations
No ligand 10mM FMN
Fusobacterium
nucleatum
Bacillus
subtilis
Fusobacterium
nucleatum
Bacillus
subtilis
Average 0.9±0.2
a 1.0±0.2 0.7±0.1 0.8±0.1
Lowest 0.1±0.02 0.1±0.02 0.1±0.02 0.1±0.01
Highest 5.4±2.5 8.6±4.1 4.2±2.4 4.5±2.8
a[Mg
2+]1/2 values±standard error of the mean (mM).
Nucleic Acids Research, 2011,Vol.39, No. 19 8591FMN binding induces unstacking at J3/4 and a
conformational shift at J4/5
The similarity of the aptamer domain global structure
in absence and in presence of ligand as characterized
by SHAPE and by previous studies (17–19,24) prompted
us to crystallize the aptamer domain of F. nucleatum
in absence of ligand. This strategy had been previously
successful for the lysine and the SAM-I riboswitches,
for which it helped delineate ligand-induced conform-
ational changes (13,16). First, we sought to optimize the
Figure 3. Temperature-dependent chemical probing of the F. nucleatum and B. subtilis RNAs. (a) Long run (top) and short run (bottom), obtained
with the F. nucleatum riboswitch. (b) Long run (top) and short run (bottom), obtained with the B. subtilis riboswitch [aligned in SAFA (34,35)].
Temperature was varied by 5 C increments in a 20–90 C range. Arrowheads: residues of interest (see main text). Full-length gels and additional
control experiments shown in Supplementary Figure S3. (c) Representation of the average Tm per residue obtained for the F. nucleatum
RNA superimposed on the F. nucleatum structure (PDB ID: 3F2Q; (19); nucleotide alignment as in Figure 1). Each phosphate group is shown
as a large sphere (available Tm value) or a small sphere (undetermined Tm value). Color according to the magnitude of the Tm difference (see
scale bar). FMN shown as sticks, and colored per atom type, with green for carbon atoms. (d) Same as (c), but with the values obtained for the B.
subtilis RNA superimposed on the F. nucleatum structure. The location of the P3a extension present in B. subtilis but not F. nucleatum is indicated by
dashed lines.
8592 Nucleic Acids Research, 2011,Vol.39, No. 19crystallization in presence of FMN of a two-piece con-
struct reported in the original publication (FnuO) (19).
We surveyed a total of 36 mutations at 18 positions in
the RNA, which resulted in a total of 378 combinations
of the two strands (Supplementary Figure S8 and
Supplementary Table S5). Crystallization and diffrac-
tion quality were the most affected by mutations of
U100 and the addition of a 30 overhang on strand ‘B’.
The best variant (FnuM) had the same sequence as that
of the original report (19), except for base pair swaps
within P4 to optimize transcription, a 50-AU-30 instead
of a 50-UU-30 overhang at the 30-end of strand ‘A’,
and a G overhang at the 30-end of strand ‘B’. While
these changes signiﬁcantly shortened crystallization time
(from 1–4 weeks to 24h), they did not yield any improve-
ment in resolution (Table 2). At 2.95A ˚ resolution, the 3D
structures of FnuM and FnuO bound to FMN were iden-
tical (maximum likelihood rmsd=0.06A ˚ ), which war-
ranted the use of the faster crystallizing FnuM for
crystallization trials in absence of ligand.
Crystals of FnuM in absence of ligand also grew in  24h,
but diffracted to lower resolution (3.3A ˚ ; Table 2). The
RNA was also more disordered, as indicated by the
higher average atomic displacement parameter than for
the structure of the bound form (Table 2). Similar trends
of lower resolution and higher disorder were previously
observed for free forms of riboswitches (13,16).
However, similar crystallization conditions, identical
space group and similar cell parameters suggested that
the global structure of the RNA was retained, thus
leading to crystal formation through similar packing inter-
actions. Furthermore, we noticed that the structure of
FnuM bound to FMN could be obtained as well by
adding FMN to the cryoprotecting solution prior to
data collection (data not shown). Hence, the crystallized
free RNA was capable of productively binding FMN,
indicating it was in an active state.
A superimposition of the 3D structures of the free form
of FnuM over the FMN-bound form of FnuM
and nine structures of FnuO solved previously (19)
showed a similar global fold (maximum likelihood
rmsd=0.17 A ˚ ; Figure 4a). Structural differences were
limited to P1, P4 and J4/5, as inferred previously from
the structures of FnuO bound to diverse ligands (19). A
comparison between the free and FMN-bound forms
of FnuM indicated that with shifts of 3.9 and 4.5A ˚
between the phosphate atoms of respectively U61 and
G62 in the free and FMN-bound structures, the magni-
tude of the structural changes was the greatest for J4/5.
This ﬁnding is similar to observations made in sev-
eral studies of the SAM-I riboswitch aptamer, which
found localized ﬂexibility within joining regions and/or
the binding pocket provided access for S-adenosylme-
thione to a buried and mostly preorganized binding site
(13,48).
Although the backbone atoms of nucleotides in J3/4 are
superimposable in the free- and FMN-bound structures,
base-stacking alterations occurred upon ligand binding
(Figure 4b). In particular, A48 and A49 stack against
each other to promote same-strand stacking from P3
through J3/4 to P4 in absence of ligand. But in presence
of FMN, A48 stacks instead against the ﬂavin moiety of
FMN (19), resulting in a shift of the base of  3A ˚ . A49
shifts away from the binding site but remains stacked
against P4 (Figure 4b) and forms hydrophobic inter-
actions with FMN (19). Such movements result in the
disruption of the Watson–Crick A49–U60 pair, and of
the interaction involving the Watson–Crick faces of A48
and U61 (Figure 4c and d; Supplementary Figure S9).
Together, these local conformational differences are
consistent with the results from the SHAPE surveys
(Figures 2 and 3) in that they occur precisely at joining
regions J3/4 and J4/5. Furthermore, the higher [Mg
2+]1/2
values observed for J3/4 in presence of FMN for
F. nucleatum (Figure 2d) could be accounted for by the
reorganization these nucleotides underwent during bind-
ing. The fact that no structural differences were ob-
served for joining regions J1/2 and J6/1 could be
attributed to the energetic stabilization of similar con-
formations by crystal packing. But as neighboring mol-
ecules are >9A ˚ away from J1/2 and J6/1, this similarity
in conformation could instead suggest these joining
regions were able to adopt a pre-folded conformation in
absence of ligand.
Table 2. Data collection and structure reﬁnement statistics
Free FMN bound
Data collection
Space group P3121 P3121
Cell dimensions
a=b, c (A ˚ ); a=b, g .
73.5, 135.2; 90, 120 73.7, 139.3; 90, 120
Wavelength (A ˚ ) 0.9795 0.9795
Resolution range (A ˚ ) 40–3.3 (3.42–3.30)
a 40–2.95 (3.06–2.95)
No. of observed
reﬂections
38995 83959
No. of unique reﬂections 6627 (593) 17834 (1773)
Redundancy 5.9 (4.0) 4.7 (4.7)
Completeness (%) 98.1 (90.1) 99.3 (100)
<I/s(I)> 22.9 (2.8) 21.7 (3.4)
Rmerge (%) 9.0 (47.5) 5.1 (47.9)
Reﬁnement
Resolution range (A ˚ ) 29.9–3.3 (4.2–3.3) 26.3–2.95 (3.36–2.95)
No. of reﬂections 6383 9559
No. of reﬂections
(test set)
356 507
Rwork (%) 20.6 (26.4) 20.4 (26.4)
Rfree (%) 25.7 (29.9) 23.1 (32.2)
No. atoms; mean atomic
displacement parameters (A ˚ 2)
RNA 2374; 135.6 2394; 98.9
Ligand/ion 40; 143.3 64; 78.8
Water – 11; 68.9
Deviations from ideal values (rmsd)
Bonds (A ˚ ) 0.002 0.003
Angles ( ) 0.517 0.612
ML-based
coordinate error (A ˚ )
0.4 0.4
All-atom clashscore,
percentile
b
16.35, 97th 13.00, 96th
PDB ID 2YIF 2YIE
Values for the outer shell are given in parentheses.
aValues for the highest resolution shell are given in parentheses.
bCalculated by MOLPROBITY (45).
Nucleic Acids Research, 2011,Vol.39, No. 19 8593Could the magnesium ion that mediates interactions
between FMN and the RNA be absent when FMN is not
bound?
As observed for the thiamine pyrophosphate and glycine
riboswitches (9,49,50), a cation mediates interactions be-
tween the ligand and the RNA in the binding pocket of the
FMN riboswitch (19). Speciﬁcally, a penta-hydrated mag-
nesium ion is coordinated to N7 of G33 (ﬁrst coordination
sphere) and to oxygen atoms belonging to FMN, G32,
U34, G41 and G62 (second coordination sphere) (19).
These contacts are also observed in the FMN-bound
structure of FnuM (Figure 4d and e). However, no mag-
nesium ion is observed in the free structure at that position
(Figure 4e). Additionally, the [Mg
2+]1/2 values calculated
for G33 of F. nucleatum are 1.7±0.2mM in absence of
FMN, and 0.3±0.1mM in presence of FMN (Figure 2d,
Supplementary Tables S1 and S2). This  5-fold decrease
of the [Mg
2+]1/2 value is consistent with a lower occupa-
tion of that magnesium-binding site in absence of ligand
(further insights could not be gained from the B. subtilis
equivalent of G33 (residue G57) as it shows no folding
cooperativity; Supplementary Figure S3). Nonetheless,
two factors could currently account for the absence of a
magnesium ion at that site in the free structure: (i) the
overall 23% decrease in occupation of magnesium-binding
sites (from 14 to 11 sites) between the FMN-bound struc-
ture and the free structure of FnuM; (ii) G32, G41, G62
in F. nucleatum (and analogously G56, G84, G114 in
B. subtilis) had the same low [Mg
2+]1/2 value (<0.5mM)
in both the free and the FMN-bound RNA
(Supplementary Tables S1 and S2). As a consequence,
while our data suggest that FMN is required to support
binding of a magnesium ion at this position, further ex-
periments will be needed to clarify this issue.
DISCUSSION
Prior evidence collected for the FMN aptamer domain
pointed at predominantly local conformational changes
of the RNA upon FMN binding (17–19). The present
Figure 4. Reorganization of the J3/4 and J4/5 joining regions upon ligand binding. (a) Overlay of crystal structures of the F. nucleatum riboswitch
from this work (light blue, free form, PDB ID 2yif; dark blue, FMN-bound form, PDB ID 2yie) on previously solved structures [gray, ﬁve
FMN-bound structures; green, FMN-bound structure in presence of cobalt hexamine; gold, Roseoﬂavin- and Riboﬂavin-bound structures (19)].
FMN atoms shown as dark blue spheres. (b) Base orientations at and near J3/4 in the free and FMN-bound forms. (c) and (d) Conformational
changes at the FMN-binding site. FMN colored per atom type (dark blue carbon atoms). (e) A magnesium ion could be present at the binding site
only in presence of FMN.
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under conditions that modulate the folding process of
the B. subtilis and F. nucleatum variants of this aptamer
allowed us to pinpoint ligand-induced structural changes
to four of the six joining regions (J1/2, J3/4, J4/5 and
J6/1). Our temperature surveys are consistent between
the two RNAs and lead us to propose that J1/2 and
J6/1 act as ﬂexible gates to the binding pocket, in a
similar fashion to J2/3 in the purine riboswitch (20,32)
and to J1/2–J3/4 in the SAM-I riboswitch (13,48). Our
ﬁndings hint at a distinct but complementary role for
J3/4 and J4/5. Both same-strand base stacking interactions
involving J3/4 and base pairing interactions between nu-
cleotides in J3/4 and J4/5 keep the binding site in a rela-
tively ‘open’ state in absence of ligand. These RNA–RNA
interactions are replaced by RNA–FMN interactions to
support a ‘closed’ ligand-bound form (Figure 4). The
role of J3/4 and J4/5 then seems to be similar to that of
A46 in the SAM-I riboswitch (13), in the sense that they
prevent a collapse of the binding site, although they do not
necessarily act as ‘place holders’ for the ligand. In short,
J1/2 and J6/1 allow access to the binding site, while J3/4
and J4/5 participate in maintaining a structure of the bind-
ing pocket that is conducive to ligand binding. Further
studies are needed to reveal when and how the uracil-like
edge and the ribose-phosphate moiety of FMN are re-
cognized by J1/2, J6/1 and a metal ion (19). Together,
such considerations about relative ﬂexibility at the binding
site and chronology of binding events would represent cru-
cial knowledge for the most effective drug design strategies
that afford to take RNA dynamics into account (51–53).
The globally preorganized and bound-like structure of
the free FMN riboswitch aptamer domain is reminiscent
of observations of other riboswitches, including the lysine
riboswitch (16), the SAM-I, -II and -III riboswitches
(13,27–29), the preQ1 riboswitch from T. tengcongensis
(12), and even an artiﬁcial neomycin-dependent riboswitch
(54,55). At physiological concentrations of magnesium
(typically 0.5–1.5mM) but in absence of ligand, these
riboswitches adopt interconverting conformations, some
of which are close in structure to the ligand-bound state.
How frequently the closest conformations to the ligand-
bound state are sampled by the population of the inter-
converting free states can be a characteristic of the
riboswitch class. For example, TPP riboswitches appear
to populate ligand-bound states in absence of ligand far
less frequently (17,56) than other classes (11,13,17,32)
(Figure 5). Thus, the TPP riboswitches appear to
undergo large conformational changes upon ligand
binding, whereas lysine and FMN appear to have virtually
no ligand-dependent global changes in their architecture.
Even within the same class phylogenetic variants are
observed to display different behaviors in their free
state. The free states of the SAM-I and preQ1 riboswitches
from thermophilic T. tengcongensis (12,13) are closer to
the bound-like states than their equivalents from
mesophilic B. subtilis (29) and F. nucleatum (12,57)
(Figure 5). Together with the guanine riboswitch and the
lysine riboswitch from mesophilic B. subtilis, the FMN
riboswitch from B. subtilis and F. nucleatum fall in the
category of riboswitches whose free states are more fre-
quently closer to the bound-like state.
Regardless of how close to the ligand-bound state the
conformational ensemble appears to be, it is very likely
that most riboswitches employ conformational selection as
their mechanism of ligand recognition and productive
binding (13,27,28,55,58). Conformational selection occurs
when the ligand interacts with the most bound-like popu-
lation of free states, progressively shifting the binding equi-
librium toward the bound state via favorable binding
B. subtilis pbuE adenine
T. tencongensis SAM-I 
Sargasso Sea metX SAM-II
* * *
B. subtilis metE SAM-I
F. nucleatum/B. subtilis queC preQ1
E. coli thiM/A. thaliana thiC TPP
B. subtilis/F. nucleatum FMN
B. subtilis xpt guanine
T. tencongensis preQ1
T. maritima asd Lysine 
conformational fluctuation
centered around ligand-bound
states
large conformational
fluctuation
Figure 5. Population dynamics for various riboswitches leading to ligand binding by conformational selection. The large box represents the entire
conformational space accessible by the free aptamer RNA. Within this conformational space, individual conformers (e.g. states) are populated to
varying degrees at any given point in time. States are represented by dots; the most ‘bound-like’ state is represented by a star. The larger the symbol,
the more populated the state. In this model, an individual RNA rapidly samples different states including those that are unproductive for binding
(white region) and those that are ‘bound like’ and capable of productively interacting with ligand (shaded region). Some riboswitches sparsely sample
bound like conformations and thus appear to have large ligand induced conformational changes (left), whereas others more substantially occupy
‘bound-like’ states, thus appearing to have small ligand induced conformational changes. Representative riboswitches are indicated under each panel
(organism, downstream gene, ligand).
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observed earlier with other RNA receptors for small mol-
ecules like the HIV-transactivation region (60) and the
ribosomal-decoding site (61), RNA recognition by riboso-
mal protein S15 (62), as well as more generally with DNA
and protein receptors (59,63,64). Considering that the
structures of the population ensemble of free FMN
riboswitch aptamer domains are so close to that of the
bound state (Figure 5, right), and that a bound-like free
state could be crystallized that was able to bind FMN, it is
highly likely that ligand binding to the FMN riboswitch
similarly happens principally by conformational selection.
Subsequent recognition events might include induced ﬁt of
J3/4 and J4/5, leading to the compacting of the binding
site around FMN seen in the crystal structure of the
bound state (Figure 4).
Such ligand-binding events to bound-like conformers
that would rapidly shift the ensemble toward populating
productive conformers support the kinetic control mech-
anism that was reported previously for the FMN
riboswitch and other riboswitches (5,6,57) and reviewed
in (65). Kinetic control is deﬁned by the observation
that the concentration of FMN required for half-maximal
regulatory response (T50) is greater than its afﬁnity for
RNA (KD). This behavior reﬂects that the time required
for the polymerase to reach the terminator element is
shorter than the time required for the aptamer to reach
equilibrium with respect to FMN binding (5,6). In the
short temporal window the aptamer has to interrogate
the cellular environment, minimal ligand-induced struc-
tural changes or stabilization make for a more reasonable
expectation than major structural reorganizations. In the
case of the FMN riboswitch, FMN-induced stabilization
of J1/2, J3/4, J4/5 and J6/1 would be sufﬁcient to prevent
pairing of the switching sequence at J1/2 with the comple-
mentary sequence in the downstream expression platform.
Furthermore, how such small changes would lead to the
quick genetic decision made by this riboswitch (6) could be
illustrated by recent ﬁndings using a small self-cleaving
RNA (66). Using the hairpin ribozyme as a model
system, Mahen et al. showed that in vivo, fast folding
occurs by exchange of base pairs between adjacent RNA
secondary structures, and not by complete helix dissoci-
ation. Additionally, they discussed how this rapid
exchange mechanism could account for the kinetic
control of the purine riboswitch. In light of our present
ﬁndings, such in vivo studies with riboswitches should
reveal how a small net stabilization of the aptamer
domain driven by ligand binding is able to drive the ap-
propriate regulatory response.
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